Article
B of A Securities Maintains Underperform on Hims & Hers Health, Lowers Price Target to $21
B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Underperform and lowers the price target from $26 to $21.
Comments
- No comments yet. Be the first to comment!